
œ
	
protein
ABI1 Abelson interactor 1
Â #
!ABLM1 Actin-binding LIM protein 1
AFAD Afadin
Â 
Â 
AHNAK Ahnak protein&
$BAIP2 Insulin receptor substrate p53
BCAR1 p130cas
Â 
Â /
-CASL CRK-associated substrate-related protein
CAV1 Caveolin-1
CDH11 Cadherin-11
CDV3 Protein CDV3
Â 
CTND1 Catenin delta-1
Â 
Â 
Â 
Â 
Â 
Â 
Â 
Â 
DBNL Actin-binding protein 1
Â 
DOK1 Docking protein 1
E41L3 Band 4.1-like protein 3'
%EGFR Epidermal growth factor receptor
Â 
Â 

EMD Emerin
Â 
Â .
,EPS8 Epidermal growth factor receptor kinase
FAK1 Focal adhesion kinase 1
Â 3
1IFITM3 Interferon-induced transmembrane protein 3
Â "
 KIRR1 Kin of IRRE-like protein 1
Â 
Â 
Â 
Â 
Â (
&LPP Lipoma-preferred partner homologue
Â 
Â 
Â 
Â 
Â *
(PARD3 Partitioning-defective 3 homologue
Â 
PAXI Paxillin
Â  
PCDHGC3 Protocadherin gamma C33
1PEAR1 Platelet endothelial aggregation receptor 15
3PGFRA Platelet-derived growth factor receptor alpha
Â 
Â 
PKP4 Plakophilin-4
PLCG1 PLCÎ³!
Q3UGC2 Cortactin, isoform CRA_e"
 RBM3 RNA-binding motif protein 3
Â 
SCAM3 Scamp3@
>SHIP2 Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2-
+STAM2 Signal transducing adapter molecule 2
SRC8 Cortactin
Â !
TBCB Tubulin folding cofactor B
TENC1 Tensin-2
Â 
TENS1 Tensin-10
.TERA Transitional endoplasmic reticulum ATPase,
*ZDHC8 Probable palmitoyltransferase ZDHHC8!
ZO1 Tight junction protein ZO-1
Â 
Â 
Á

phosphopeptide
NTPpYKTLEPVKPPTVPNDpYMTSPAR
TLEPVKPPTVPNDpYMTSPAR
STSQGSINSPVpYSR
LAAEVpYKDMPETSFTR

EpYFTFPASK
SQEELREEKVpYQLER
VKGEpYDVTMPK
LSDSpYSNTLPVRK
TQQGLpYQAPGPNPQFQSPPAK
GLLSSSHHSVpYDVPPSVSK
RPGPGTLpYDVPR
LpYQVPNSQAASR
YVDSEGHLpYTVPIR
KDIKPEpYQYMPR
KTPQGPPEIpYSDTQFPSLQSTAK
LQLDNQpYAVLENQK
LNGPQDHNHLLpYSTIPR 
TVQPVPMGPDGLPVDASAVSNNpYIQTLGR!
NFHYPPDGYGRHYEDGpYPGGSDNpYGSLSR
HYEDGYPGGSDNpYGSLSR

YRPSMEGpYR
QDVpYGPQPQVR
FHPEPpYGLEDDQR
SQSSHSpYDDSTLPLIDR
SLDNNpYSTLNERGDHNR
ESTSFQDVGPQAPVGSVpYQK
QLTQPETSpYGREPTAPVSR
TVPPPVPQDPLGSPPALpYAEPLDSLR
SLDGEVGTGQpYATTK
LLGAEEKEpYHAEGGKVPIK
RPAGSVQNPVpYHNQPLHPAPGR
GPTAENAEpYLR
TpYGEPESVGMSK
LIYGQDSApYQSIAHYRPISNVSR
LIYGQDSAYQSIAHpYRPISNVSR
STPNHQVDRNpYDAVK
AAApYLDPNLNHTPSSSTK
YMEDSTpYpYKASK
MNHTSQAFITAASGGQPPNpYER
IKEEpYEVAEMGAPHGSASVR
AVLpYADYRAPGPTR
AVLYADpYRAPGPTR
AVLpYADpYRAPGPTR
TPpYEApYDPIGK
TPYEApYDPIGK
FSYTSQHSDpYGQRFQQR
SAQPSPHpYMAGPSSGQIpYGPGPR
SAQPSPHYMAGPSSGQIpYGPGPR
YpYEPYYAAGPSYGGR
YYEPYpYAAGPSYGGR
SEGDTApYGQQVQPNTWK
EAApYAPPASGNQNHPGMYPVSGPK
ESVSTSSDQPSpYSLER
ERDpYAEIQDFHR
YAHQQPPSPLPVpYSSSAK
AGEEEHVpYSFPNK
	APVSSLpYR
ESGpYVEMKGPPSVSPPR
QADTTQpYVPMLER
SLpYDRPASYK
LSADSGpYIIPLPDIDPVPEEEDLGKR
LQHQQLpYpYQDDSTRK

pYQQPFEDFR
HESQQDpYAKGFGGK
YDSRPGGYGpYGYGR
YSGGNYRDNpYDN
NpYGSYSTQASAAAATAELLK
TLSEVDpYAPGPGR
LVNEAPVpYSVYSK
HASQKDpYSSGFGGK
NASTFEEVVQVPSApYQK
LGEpYEDVSKVEK
GPLDGSPpYAQVQR
LALPTAALpYGLR
HAApYGGYSTPEDR+
)GFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLpYG
KVSGVGGTTpYEISV
YRPEAQPpYSSTGPK
SpYEQVPPPGFTSK
HEEQPAPApYEVHNR
–

phosphosite(s)
pY197, pY212
pY212
pY505
pY203
pY1230
pY1285
pY963
pY338
pY132
pY310
pY391
pY91
pY14
pY700
pY213
pY267
pY96
pY174
pY221, pY228
pY228
pY248
pY257
pY280
pY865
pY904
pY162
pY305
pY295
pY453
pY871
pY1110
pY1197
pY106
pY161
pY167
pY524
pY4
pY614, pY615
pY20
pY27
pY654
pY657
pY654, pY657
pY753, pY756
pY756
pY777
pY235, pY245
pY245
pY297
pY302
pY318
pY333
pY969
pY1076
pY88
pY118
pY735
pY41
pY742
pY762
pY1018
pY1114, pY1115
pY1253
pY302
pY124
pY151
pY85
pY1136
pY371
pY154
pY334
pY98
pY483
pY705
pY1477
pY805
pY711
pY1177
pY1198
pY1164
ß

SILAC ratio
0.083
0.561
0.195
0.259
0.482
0.202
0.316
0.164
0.221
0.577
0.326
0.352
0.378
0.265
0.143
0.162
0.530
0.382
0.173
3.003
0.155
0.254
0.289
0.116
0.429
0.092
0.044
0.579
0.353
0.203
0.385
0.555
0.074
0.089
0.054
0.504
0.174
0.343
0.576
0.433
2.348
0.350
0.432
0.467
1.771
0.484
0.032
0.063
0.266
0.269
0.137
0.071
0.118
0.514
0.395
0.501
0.528
0.138
0.443
0.410
0.162
0.387
0.518
0.291
0.204
0.318
0.333
0.560
0.113
0.201
0.085
0.172
0.245
0.204
0.293
0.111
0.432
0.038
0.208
0.112
Ô

% variability
56.942
79.405
Â 
85.353
41.237
43.666
Â 
Â 
Â 
22.478
23.664
38.486
3.108
13.550
33.332
Â 
32.209
17.762
23.705
21.770
44.702
30.310
60.708
45.682
35.851
18.622
53.280
19.218
Â 
40.247
39.984
44.154
25.481
33.376
Â 
Â 
21.969
15.339
18.836
26.578
Â 
Â 
19.452
Â 
20.387
Â 	
173.794	
111.089
Â 
10.928
96.380
65.503
Â 
16.397
31.523
24.616
Â 
Â 
32.533
32.001
38.489
5.041
5.699
17.822
Â 
44.561
30.094
31.372
27.025
Â 
32.432
Â 
38.913
Â 
Â 
Â 
Â 
62.278
58.171
50.945LPhosphotyrosine Peptides Significantly Changed Due to the Presence of SU66563
Unknown
PMC2950672Unknown"PMC2950672tbl1.html